Application of transient elastography in nonalcoholic fatty liver disease
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2020;26(2):128-141.   Published online 2019 Nov 8     DOI: https://doi.org/10.3350/cmh.2019.0001n
Citations to this article as recorded by Crossref logo
Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma
Mohamed El-Kassas, Heba A. Othman, Mohamed Elbadry, Khalid Alswat, Yusuf Yilmaz
Journal of Clinical and Experimental Hepatology.2025; 15(1): 102415.     CrossRef
Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
User Engagement, Acceptability, and Clinical Markers in a Digital Health Program for Nonalcoholic Fatty Liver Disease: Prospective, Single-Arm Feasibility Study
Sigridur Björnsdottir, Hildigunnur Ulfsdottir, Elias Freyr Gudmundsson, Kolbrun Sveinsdottir, Ari Pall Isberg, Bartosz Dobies, Gudlaug Erla Akerlie Magnusdottir, Thrudur Gunnarsdottir, Tekla Karlsdottir, Gudlaug Bjornsdottir, Sigurdur Sigurdsson, Saemundu
JMIR Cardio.2024; 8: e52576.     CrossRef
Focused Shear Wave Beam Propagation in Tissue-Mimicking Phantoms
John M. Cormack, Yu-hsuan Chao, Branch T. Archer, Kang Kim, Kyle S. Spratt, Mark F. Hamilton
IEEE Transactions on Biomedical Engineering.2024; 71(2): 621.     CrossRef
Development of Cost-Effective Fatty Liver Disease Prediction Models in a Chinese Population: Statistical and Machine Learning Approaches
Liang Zhang, Yueqing Huang, Min Huang, Chun-Hua Zhao, Yan-Jun Zhang, Yi Wang
JMIR Formative Research.2024; 8: e53654.     CrossRef
Exploring the link: magnesium intake and hepatic steatosis in Americans
Xingxing Chen, Liying Fu, Zhongxin Zhu, Yunchao Wang
Frontiers in Nutrition.2024;[Epub]     CrossRef
The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease
Hye Won Lee, Kun Hee Kim, Sang Hoon Ahn, Han Chu Lee, Jonggi Choi
Liver International.2024; 44(6): 1448.     CrossRef
A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL
Bilal A. Mir, Brij Sharma, Rajesh Sharma, Vishal Bodh, Ashish Chauhan, Tahir Majeed, Inaamul Haq, Neetu Sharma, Dikshant Sharma
Journal of Clinical and Experimental Hepatology.2024; 14(5): 101398.     CrossRef
Comparative value of controlled attenuation (CAPc) and continuous controlled attenuation (CAP) parameters for different stages of non-alcoholic fatty liver disease
A. A. Goncharov, A. N. Sasunova, V. A. Isakov
Experimental and Clinical Gastroenterology.2024; (2): 55.     CrossRef
Exploring the association between dietary fiber intake and hepatic steatosis: insights from NHANES
Xingxing Chen, Liying Fu, Zhongxin Zhu, Yunchao Wang
BMC Gastroenterology.2024;[Epub]     CrossRef
Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
Eugene Han, Yong-ho Lee, Sang Hoon Ahn, Bong-Soo Cha, Seung Up Kim, Byung-Wan Lee
Gut and Liver.2024; 18(3): 509.     CrossRef
Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria
Eline C. B. Eskes, Laura van Dussen, Marion M. M. G. Brands, Frédéric M. Vaz, Johannes M. F. G. Aerts, André B. P. van Kuilenburg, Barbara Sjouke, Carla E. M. Hollak
Journal of Inherited Metabolic Disease.2024;[Epub]     CrossRef
Associations between allostatic load and hepatic steatosis and liver fibrosis: evidence from NHANES 2017–2020
Zhikun Dai, Xiaohui Zhou
BMC Public Health.2024;[Epub]     CrossRef
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
Consolato M. Sergi
International Journal of Molecular Sciences.2024; 25(15): 8462.     CrossRef
Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease
Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Alimentary Pharmacology & Therapeutics.2024; 60(8): 1051.     CrossRef
Electrical and Viscoelastic Parameters of Erythrocytes as a Part of Diagnostic Models for Differentiating Fatty Liver Disease of Mixed Genesis from Non-Alcoholic and Alcohol-Related Fatty Liver Disease
M. V. Kruchinina, M. F. Osipenko, M. V. Parulikova, A. A. Gromov
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2024; 34(3): 38.     CrossRef
Diagnostic models for differentiating fatty liver disease of alcohol and non-alcoholic genesis
M. V. Kruchinina, M. F. Osipenko, M. V. Parulikova, A. V. Belkovets, E. V. Kruchinina
Meditsinskiy sovet = Medical Council.2024; (15): 80.     CrossRef
Жирные кислоты мембран эритроцитов как биомаркеры неалкогольной жировой болезни печени у мужчин
М. В. Кручинина, М. В. Паруликова, Н. Е. Першина, Э. В. Кручинина
Ateroscleroz.2023; 18(4): 362.     CrossRef
Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018
Julia Y. Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy
Hepatology Communications.2023; 7(1): e0019.     CrossRef
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Nila Jambulingam, Roberta Forlano, Benjamin Preston, Benjamin H. Mullish, Greta Portone, Yama Baheer, Michael Yee, Robert D. Goldin, Mark R. Thursz, Pinelopi Manousou
International Journal of Molecular Sciences.2023; 24(4): 3563.     CrossRef
Special Population
Ajay Duseja, Arka De, Vincent Wong
Clinics in Liver Disease.2023; 27(2): 451.     CrossRef
How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee
Ultrasonography.2023; 42(2): 227.     CrossRef
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(8): 1372.     CrossRef
Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial
Lygia N. Barroso, Jessica Salarini, Nathalie Carvalho Leite, Cristiane A. Villela-Nogueira, Alberto Dávalos, Maria das Graças Tavares Carmo, Wilza Arantes Ferreira Peres
Clinical Nutrition ESPEN.2023; 57: 117.     CrossRef
B-mode shear wave elastography can be an alternative method to vibration-controlled transient elastography according to a moderate-scale population study
Masashi Hirooka, Yohei Koizumi, Yoshiko Nakamura, Ryo Yano, Kana Hirooka, Makoto Morita, Yusuke Imai, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa
Journal of Medical Ultrasonics.2023; 50(4): 473.     CrossRef
Advanced liver fibrosis predicts heart failure and hospitalizations in people with type 2 diabetes: A prospective cohort study from Hong Kong Diabetes Register
Alice Pik-Shan Kong, Eric Siu-Him Lau, Chun-Kwan O, Andrea On-Yan Luk, Terry Cheuk-Fung Yip, Elaine Yee-Kwan Chow, Raymond Kwok, Hye Won Lee, Grace Lai-Hung Wong, Ronald Ching-Wan Ma, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Juliana Chung-Ngor Chan
Diabetes Research and Clinical Practice.2023; 202: 110825.     CrossRef
Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta‐analysis
Run Zhou, Luping Yang, Binbin Zhang, Yunpeng Gu, Tingting Kong, Wei Zhang, Lei Sun, Chunlan Liu, Ningjia Kong, Jie Li, Junping Shi
Journal of Viral Hepatitis.2023; 30(10): 793.     CrossRef
Analysis of clinical features and identification of risk factors in patients with non-alcoholic fatty liver disease based on FibroTouch
Yan Liao, Lei Liu, Jiayao Yang, Xiaoli Zhou, Xiaoli Teng, Yixi Li, Ying Wan, Jian Yang, Zhaohong Shi
Scientific Reports.2023;[Epub]     CrossRef
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic‐associated fatty liver disease
Johnny T. K. Cheung, Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip, Huapeng Lin, Guanlin Li, Howard Ho‐Wai Leung, Jimmy Che‐To Lai, Sanjiv Mahadeva, Nik Raihan Nik Mustapha, Xiao‐Dong Wang, Wen‐Yue Liu, Vincent Wai‐Sun Wong, Wah‐Kheong Chan, Mi
Alimentary Pharmacology & Therapeutics.2023; 58(11-12): 1194.     CrossRef
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
Alexey A. Goncharov, Armida N. Sasunova, Vladimir I. Pilipenko, Vasily A. Isakov
Terapevticheskii arkhiv.2023; 95(8): 641.     CrossRef
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis
Xinrong Zhang, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Guanlin Li, Huapeng Lin, Lilian Yan Liang, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Stephen Lam Chan, Alice Pik-Shan Kong, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Hepatology.2023; 78(6): 1816.     CrossRef
Low Relative Handgrip Strength Is Associated with a High Risk of Non-Alcoholic Fatty Liver Disease in Italian Adults: A Retrospective Cohort Study
Samantha Maurotti, Roberta Pujia, Elisa Mazza, Maria Francesca Pileggi, Franco Arturi, Maria Grazia Tarsitano, Tiziana Montalcini, Arturo Pujia, Yvelise Ferro
Applied Sciences.2023; 13(22): 12489.     CrossRef
Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations
Alina Boeriu, Daniela Dobru, Crina Fofiu
Life.2023; 13(12): 2262.     CrossRef
Non-alcoholic fatty liver disease in obese subjects as related to increasing insulin resistance and deteriorating glucose control: Three years of follow-up from a longitudinal survey
Thomas Forst, Isabel Botz, Matthias Berse, Stephan Voswinkel, Mares-Elaine Strempler, Sybille Baumann, Maria Marinez
Journal of Diabetes & Metabolic Disorders.2023; 23(1): 999.     CrossRef
Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases?
Jimmy Che-To Lai, Lilian Yan Liang, Grace Lai-Hung Wong
Gastroenterology Report.2023;[Epub]     CrossRef
Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Diabetologia.2022; 65(3): 518.     CrossRef
Diagnostic Performance of 2-D Shear Wave Elastography on the Evaluation of Hepatic Fibrosis with Emphasis on Impact of the Different Region-of-Interest Methods
Eun Mi Kim, Ji-Won Park, Sang Min Lee, Min-Jeong Kim, Hong Il Ha, Sung-Eun Kim, Eun Soo Kim, Young Chul Kim, Kwanseop Lee
Ultrasound in Medicine & Biology.2022; 48(2): 198.     CrossRef
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design
Pierpaolo Pellicori, Muthiah Vaduganathan, João Pedro Ferreira, Faiez Zannad, Arun J. Sanyal
Diabetes & Metabolism.2022; 48(2): 101281.     CrossRef
Controlled attenuation parameter measured using transient elastography for the noninvasive assessment of macrovesicular steatosis in potential living liver donors
Sunyoung Lee, Kyoung Won Kim, So Yeon Kim, Nieun Seo, Gi-Won Song, Sung-Gyu Lee
Ultrasonography.2022; 41(1): 164.     CrossRef
Transient Elastography–Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States
Aynur Unalp-Arida, Constance E. Ruhl
Clinical Gastroenterology and Hepatology.2022; 20(4): e808.     CrossRef
Non-invasive tests of non-alcoholic fatty liver disease
Guanlin Li, Xinrong Zhang, Huapeng Lin, Lilian Yan Liang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Chinese Medical Journal.2022; 135(5): 532.     CrossRef
Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jae Young Jang, Soo Young Park, Hyun Woong Lee, Chun Kyon Lee, Seung Up Kim
Frontiers in Medicine.2022;[Epub]     CrossRef
Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
Wen Guo, Xin Zhao, Mengyuan Miao, Xiuru Liang, Xiaona Li, Pei Qin, Jing Lu, Wenfang Zhu, Juan Wu, Chen Zhu, Nianzhen Xu, Qun Zhang
Frontiers in Nutrition.2022;[Epub]     CrossRef
Vibration-controlled Transient Elastography in NAFLD: Review Study
Hasan Ozkan, Abdullah M Ozercan
Euroasian Journal of Hepato-Gastroenterology.2022; 12(S1): S41.     CrossRef
Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
Abdominal Radiology.2022; 47(11): 3733.     CrossRef
DETERMINANTS OF SIGNIFICANT HEPATIC FIBROSIS IN TYPE 2 DIABETES PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN SOUTH INDIA.
A V Ramya, P Thirumal
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2022; : 24.     CrossRef
Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization
David T. Fetzer, Ivan M. Rosado-Mendez, Michael Wang, Michelle L. Robbin, Arinc Ozturk, Keith A. Wear, Juvenal Ormachea, Timothy A. Stiles, J. Brian Fowlkes, Timothy J. Hall, Anthony E. Samir
Radiology.2022; 305(2): 265.     CrossRef
The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Haofei Hu, Yong Han, Changchun Cao, Yongcheng He
Journal of Translational Medicine.2022;[Epub]     CrossRef
Clinical Feasibility of Quantitative Ultrasound Imaging for Suspected Hepatic Steatosis: Intra- and Inter-examiner Reliability and Correlation with Controlled Attenuation Parameter
Sun Kyung Jeon, Jeong Min Lee, Ijin Joo
Ultrasound in Medicine & Biology.2021; 47(3): 438.     CrossRef
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clinical and Molecular Hepatology.2021; 27(1): 44.     CrossRef
Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography
Jae Hyon Park, Nieun Seo, Yong Eun Chung, Seung Up Kim, Yung Nyun Park, Jin-Young Choi, Mi-Suk Park, Myeong-Jin Kim
European Radiology.2021; 31(7): 4813.     CrossRef
Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
Wayne Eskridge, John M. Vierling, Wayne Gosbee, Gabriella A. Wan, May-Linh Hyunh, Henry E. Chang, Daisuke Tokuhara
PLOS ONE.2021; 16(11): e0260320.     CrossRef
A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery
Shirley Yuk-Wah Liu, Vincent Wai-Sun Wong, Simon Kin-Hung Wong, Grace Lai-Hung Wong, Carol Man-sze Lai, Candice Chuen-Hing Lam, Sally She-Ting Shu, Henry Lik-Yuen Chan, Enders Kwok-Wai Ng
Scientific Reports.2021;[Epub]     CrossRef
Ultrasound Elastography in Liver Tissue: Current Status
Zhang, MD Mingzhu, Ding, MD Zhaoyan, Niu, MD Xiaoyan, Gao, MD Yuxiu, Zhao, MD Cheng
ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY.2021; 5(3): 197.     CrossRef
Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan
Diagnostics.2021; 11(5): 842.     CrossRef
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications
T. Hydes, E. Brown, A. Hamid, A.C. Bateman, D.J. Cuthbertson
Clinical Therapeutics.2021; 43(9): 1505.     CrossRef
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bue
Experimental and Clinical Gastroenterology.2021; 1(1): 4.     CrossRef
Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
V. P. Kovyazina, K. L. Raikhelson, M. K. Prashnova, E. V. Pazenko, L. K. Palgova, E. A. Kondrashina
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2021; 31(1): 31.     CrossRef
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Jae Seung Lee, Dong Hyun Sinn, Soo Young Park, Hye Jung Shin, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Joo Hyun Oh, Jung Il Lee, Seung Up Kim
Cancers.2021; 13(18): 4567.     CrossRef
Diagnostic Performance of Noninvasive Methods for Liver Biopsy by Fibroscan in Pediatric
Ghobad Heidari, Farzaneh Motamed, Bita Heirati, Parisa Rahmani
Journal of Child Science.2021; 11(01): e55.     CrossRef
The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
James Neuberger, Owen Cain
Hepatic Medicine: Evidence and Research.2021; Volume 13: 59.     CrossRef
Clinical relevance of dynamic risk assessment for developing hepatocellular carcinoma during prolonged antiviral therapy
Han Ah Lee, Beom Kyung Kim, Seung Up Kim
Journal of Hepatology.2020; 73(1): 222.     CrossRef
A Survey of Liver Cancer Specialists’ Views on the National Liver Cancer Screening Program in Korea
Won Sohn, Young-Sun Lee, Jae Geun Lee, Jihyun An, Eun Sun Jang, Dong Ho Lee, Dong Hyun Sinn
Journal of Liver Cancer.2020; 20(1): 53.     CrossRef
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
Janae Wentong Wai, Charmaine Fu, Vincent Wai-Sun Wong
Journal of Gastroenterology.2020; 55(8): 731.     CrossRef
High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Jun Yong Park
Journal of Viral Hepatitis.2020; 27(11): 1119.     CrossRef
Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease
Seong Hee Kang, Soon Koo Baik, Moon Young Kim
Journal of Korean Medical Science.2020;[Epub]     CrossRef
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea
Cancers.2020; 12(10): 2778.     CrossRef
Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
Anurag Mishra, Tamara R. Castañeda, Erik Bader, Bettina Elshorst, Sheila Cummings, Petra Scherer, Dinesh S. Bangari, Claudia Loewe, Herman Schreuder, Christoph Pöverlein, Mike Helms, Seth Jones, Gernot Zech, Thomas Licher, Michael Wagner, Manfred Schudok,
Advanced Science.2020;[Epub]     CrossRef
Diagnostic Accuracy of FibroScan and Factors Affecting Measurements
Satoshi Oeda, Kenichi Tanaka, Ayaka Oshima, Yasue Matsumoto, Eisaburo Sueoka, Hirokazu Takahashi
Diagnostics.2020; 10(11): 940.     CrossRef
Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
Omesh Goyal, Sahil Nohria, Prerna Goyal, Jaskirat Kaur, Sarit Sharma, Ajit Sood, Rajoo Singh Chhina
Scientific Reports.2020;[Epub]     CrossRef
Effects of Ademetionine on Liver Fibrosis, Level of Pentraxin-3 and Metabolic Indicators in Patients with Comorbid Course of Non-alcoholic Liver Disease and Arterial Hypertension
T. N. Alexandrova, O. Ya. Babak
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2020; 5(6): 95.     CrossRef
East Asia expert opinion on treatment initiation for chronic hepatitis B
Jia‐Horng Kao, Tsung‐Hui Hu, Jidong Jia, Masayuki Kurosaki, Young‐Suk Lim, Han‐Chieh Lin, Dong Hyun Sinn, Yasuhito Tanaka, Vincent Wai‐Sun Wong, Man‐Fung Yuen
Alimentary Pharmacology & Therapeutics.2020; 52(10): 1540.     CrossRef
Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack
Minyoul Baik, Hyo Suk Nam, Ji Hoe Heo, Hyung Jong Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Hye Sun Lee, Seung Up Kim, Young Dae Kim
Cerebrovascular Diseases.2020; 49(5): 474.     CrossRef